Table 2 Test measures that associate with prior SARS-CoV-2 infection.
(1) SARS-CoV-2 cases vs all controls | (2a) SARS-CoV-2 cases vs contemporary controls | (2b) The effect of SARS-CoV-2 status on the difference between pandemic and pre-pandemic measurements | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Test, trait (unit) | Cases/ctrls | Effect (95% CI) | P value | Cases/ctrls | Effect (95% CI) | P value | Cases/ctrls | Effect (95% CI) | P value | |
Perceived Stress Scale (score) | Q | 901/34391 | −1.97 (−2.37 to −1.57) | 2.7E-22 | 1487/616 | −0.37 (−1.00–0.26) | 0.25 | 264/19859 | −1.63 (−2.29 to −0.97)* | 1.2E-6 |
Smell, selective anosmia | B | 1668/14090 | 3.72 (3.46–3.99) | 9.5e-19 | 1668/617 | 4.29 (3.56–5.03)* | 2.7E-6 | 122/294 | 0.06 (0.02–0.11)* | 0.0099 |
Smell, hyposmia | B | 1668/14090 | 1.88 (1.73–2.04) | 1.0E-13 | 1668/617 | 2.61 (2.24–2.97)* | 2.0E-8 | 122/294 | 0.12 (0.04–0.20)* | 0.0036 |
Taste, selective ageusia | B | 1669/615 | 2.44 (1.93–2.95) | 1.8E-4 | 1669/615 | 2.44 (1.93–2.95) | 1.8E-4 | NA$ | NA$ | NA$ |
Grip strength (kg) | Q | 1670/8154 | −0.71 (−1.10 to −0.31) | 4.9E-4 | 1670/614 | −0.66 (−1.41–0.03)* | 0.062 | 59/139 | 0.45 (−1.50–2.40) | 0.65 |
Delayed memory recall# (SD) | Q | 1602/602 | −0.24 (−0.34 to −0.14) | 3.3E-6 | 1602/602 | −0.24 (−0.34 to −0.14) | 3.3E-6 | NA$ | NA$ | NA$ |
Immediate memory recall# (SD) | Q | 1602/602 | −0.18 (−0.28 to −0.08) | 3.2E-4 | 1602/602 | −0.18 (−0.28 to −0.08) | 3.2E-4 | NA$ | NA$ | NA$ |